Eczema and Kidney Disease: Why Two Large Studies Do Not Give the Same Answer
A headline linking eczema with kidney disease can make an ordinary skin flare feel like a warning about another organ. The available research does not let a person diagnose kidney damage from their skin. It raises a narrower question: do people recorded as having atopic dermatitis also have more recorded kidney disease, and does that finding help decide who should be tested?
The Taiwan study followed diagnoses over time
A 2025 nationwide Taiwan study compared 15,179 people with atopic dermatitis with 60,716 age- and sex-matched people without it. Entry occurred during 2000–2008; follow-up ended with chronic kidney disease, death or December 31, 2013. The adjusted odds ratio for CKD was 1.30, 95% confidence interval 1.21–1.40. This is an association in administrative records, not proof that eczema injured the kidneys. The abstract does not provide an absolute risk suitable for an individual prediction.
The UK findings depended on the question
The 2021 UK primary-care analysis used two designs. Its case–control comparison included 56,602 people with CKD stages 3–5 and 268,305 controls; eczema history was associated with CKD, adjusted OR 1.14 with a 99% CI of 1.11–1.17. In a separate cohort of 335,827 people with diabetes, researchers found no evidence that eczema was associated with new CKD stages 3–5.
| Study question | What it can tell us | Important boundary |
|---|---|---|
| Taiwan follow-up | More recorded CKD in the AD group | Odds are not a personal probability |
| UK existing CKD comparison | A modest association with eczema history | Does not establish which condition caused the other |
| UK diabetes cohort | No detected association with new CKD3–5 | Specific high-risk population and kidney endpoint |
The UK authors noted possible missed silent disease, limited urine-albumin data and residual confounding. These differences in populations, testing and outcomes mean the studies should not be averaged informally into one universal “eczema kidney risk.” For the statistics vocabulary, see our guide to relative and absolute study results.
Use established risk factors to plan testing
NIDDK guidance identifies diabetes, high blood pressure, heart disease and a family history of kidney failure as reasons to discuss kidney testing. Early kidney disease may have no symptoms. Assessment commonly includes a blood test estimating filtration and a urine test for albumin. People with diabetes should be checked yearly; other testing intervals should be individualized.
A useful appointment note contains existing diagnoses, recent blood pressure readings, prior kidney results and every medicine or supplement. Ask which test is needed, what a changed result would mean, and who will review it. An eczema association headline alone does not establish a new screening schedule.
Medication monitoring is a separate decision
If cyclosporine is part of the eczema plan, its prescribed kidney and blood-pressure checks still matter regardless of these population studies. Read why cyclosporine monitoring belongs in the treatment plan. Do not stop a prescribed medicine or add a “kidney cleanse” because of a cohort statistic.
When the symptom is persistent widespread itching without a typical rash, bring that description to a clinician rather than assuming every episode is eczema; our guide to itch without an obvious rash explains that assessment question. Keep a simple record of skin changes and medical results without trying to make one substitute for the other.
A different laboratory question—eczema and thyroid testing—also requires separating group associations from the reason a particular person needs a test.
A separate role for daily skin comfort
Dr. Arsy Moisturizer #003, 4 oz / 120 g is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. It does not diagnose, treat or prevent eczema or the conditions discussed here. Product choice should follow the actual ingredient label and individual tolerability; adult cosmetic testing does not establish infant or pediatric suitability.
Educational information, not an individual diagnosis or treatment plan. Evidence checked November 9, 2026. The sports image is an AI-created editorial product visual, not a patient photograph or a clinical outcome.